BRIEF-Medicenna presents updates on phase 2b clinical trial of MDNA55 at annual meeting of society of neuro-oncology

1 分钟阅读

Nov 16 (Reuters) - Medicenna Therapeutics Corp

* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below